Gadah  Albasher

Dr. Gadah Albasher


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2021 in Environment, Development and Sustainability
Verified
Journal Article
Closed access
PDF file
ZBZulfiqar Ali Baloch
Zulfiqar Ali Baloch
QTQingmei Tan
Qingmei Tan
HKHafiz Waqas Kamran
Hafiz Waqas Kamran
MNMuhammad Atif Nawaz
Muhammad Atif Nawaz
GGadah Albasher
Gadah Albasher
JHJavaria Hameed
Javaria Hameed

26 February 2021 in Sustainability
Verified
Journal Article
Open access
PDF file
LALiaqat Ali
Liaqat Ali
Ahsan NawazAhsan Nawaz
Ahsan Nawaz
SIShahid Iqbal
Shahid Iqbal
MBMuhammad Aamir Basheer
Muhammad Aamir Basheer
JHJavaria Hameed
Javaria Hameed
Yong BaiYong Bai
Yong Bai
The emission and mitigation of greenhouse gases transforms the status of urban environments. However, a policy accounting for all the aspects associated with transport is lacking. Problems related to transport include a greater reliance on cars, increased congestion, and environmental impacts. The absence of an efficient public transport system is a notable cause of the prompt escalation of diverse problems, for example, increases in the number of personal automobiles causes congestion on the road, resulting in air pollution, ubiquitous greenhouse effects and noise pollution, which ultimately affect human health. Transit oriented development (TOD) has been suggested as a solution to these problems. This paper reviews the impacts of transit development on urban development, greenhouse impact, the environment, economy, property value, travel behavior, and health etc., highlighting the policy issues which hinder TOD. Implementation of TOD has a strong impact on shaping the urban form, redevelopment, and the upgradation of old areas. Controlling transit phenomena will also help to control the emission and mitigation of greenhouse gases. This study will help in improving the urban environment and climatic condition of regions.

1 July 2019 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
GGadah Albasher
Gadah Albasher
SASaleh Alfarraj
Saleh Alfarraj
SASaud Alarifi
Saud Alarifi
SASaad Alkhtani
Saad Alkhtani
RARafa Almeer
Rafa Almeer
AMAhmed E. Abdel Moneim
Ahmed E. Abdel Moneim

7 July 2019 in Biomolecules
Verified
Journal Article
Open access
PDF file
GGadah Albasher
Gadah Albasher
RARafa Almeer
Rafa Almeer
FAFatimah O. Al-Otibi
Fatimah O. Al-Otibi
NANoorah A. Alkubaisi
Noorah A. Alkubaisi
AMAyman Mahmoud
Ayman Mahmoud
Exposure to organophosphorus insecticides causes several health problems to animals and humans. Red beetroot (RBR) is rich in antioxidant ingredients and possesses a promising hepatoprotective activity. This study evaluated the potential of RBR extract to prevent chlorpyrifos (CPF)-induced liver injury, with an emphasis on oxidative stress, inflammation and apoptosis. Rats received 10 mg/kg CPF and were treated with 300 mg/kg RBR extract for 28 days. CPF caused liver injury evidenced by elevated serum levels of serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP) and bilirubin, along with several histological alterations. Hepatic lipid peroxidation (LPO) and nitric oxide (NO) levels, as well as inducible nitric oxide synthase (iNOS) and pro-inflammatory cytokines were increased in CPF-intoxicated rats. RBR prevented CPF-induced histological alterations, and ameliorated liver function, LPO, NO, iNOS and pro-inflammatory cytokines. RBR boosted glutathione and antioxidant enzymes, and increased Nrf2 expression. In addition, RBR diminished Bax and caspase-3, and increased Bcl-2 expression. In conclusion, RBR prevented CPF-induced liver injury via attenuation of oxidative stress, inflammation and apoptosis. RBR enhanced antioxidant defenses, suggesting that it could be used as a potential therapeutic intervention to minimize CPF hepatotoxicity.

3 February 2021 in Human & Experimental Toxicology
Verified
Journal Article
Closed access
PDF file
ADAa Dar
Aa Dar
AFAlaa Fehaid
Alaa Fehaid
SAS Alkhatani
S Alkhatani
SAS Alarifi
S Alarifi
WAWs Alqahtani
Ws Alqahtani
AMAhmed Abddel Moneim
Ahmed Abddel Moneim
Methotrexate (MTX) is frequently used drug in treatment of cancer and autoimmune diseases. Unfortunately, MTX has many side effects including the hepato-renal toxicity. In this study, we hypothesized that Luteolin (Lut) exhibits protective effect against the MTX-induced hepato-renal toxicity. In order to investigate our hypothesis, the experiment was designed to examine the effect of exposure of male rats to MTX (20 mg/kg, i.p., at day 9) alone or together with Lut (50 mg/kg, oral for 14 days) compared to the control rats (received saline). The findings demonstrated that MTX treatment induced significant increases in the liver and kidney functions markers in serum samples including Aspartate transaminase (AST), Alanine transaminase (ALT), creatinine, urea and uric acid. MTX also mediated an oxidative stress expressed by elevated malondialdehyde (MDA) level and decreased level of reduced glutathione (GSH), antioxidant enzyme activities, and downregulation of the Nrf2 gene expression as an antioxidant trigger. Moreover, the inflammatory markers (NF-κB, TNF-α, and IL-1β) were significantly elevated upon MTX treatment. In addition, MTX showed an apoptotic response mediated by elevating the pro-apoptotic (Bax) and lowering the anti-apoptotic (Bcl-2) proteins. All of these changes were confirmed by the observed alterations in the histopathological examination of the hepatic and renal tissues. Lut exposure significantly reversed all the MTX-induced changes in the measured parameters suggesting its potential protective role against the MTX-induced toxicity. Finally, our findings concluded the antioxidative, anti-inflammatory and anti-apoptotic effects of Lut as a mechanism of its protective role against the MTX-induced hepato-renal toxicity in rats.

28 July 2020 in Cancers
Verified
Journal Article
Open access
PDF file
RHReham Hamida
Reham Hamida
GGadah Albasher
Gadah Albasher
MBMashael Bin-Meferij
Mashael Bin-Meferij
Green nanoparticles represent a revolution in bionanotechnology, providing opportunities to fight life-threatening diseases, such as cancer, with less risk to the environment and to human health. Here, for the first time, we systematically investigated the anticancer activity and possible mechanism of novel silver nanoparticles (N-SNPs) synthesized by Nostoc Bahar M against the MCF-7 breast cancer cells, HCT-116 colorectal adenocarcinoma cells, and HepG2 liver cancer cells, using cell viability assays, morphological characterization with inverted light and transmission electron microscopy, antioxidants and enzymes (glutathione peroxidase (GPx), glutathione (GSH), adenosine triphosphatase (ATPase), and lactate dehydrogenase (LDH)), and western blotting (protein kinase B (Akt), phosphorylated-Akt (p-Akt), mammalian target of rapamycin (mTOR), B-cell lymphoma 2 (Bcl-2), tumor suppressor (p53), and caspase 3). N-SNPs decreased the viability of MCF-7, HCT-116, and HepG2 cells, with half-maximal inhibitory concentrations of 54, 56, and 80 µg/mL, respectively. They also significantly increased LDH leakage, enhanced oxidative stress via effects on antioxidative markers, and caused metabolic stress by significantly decreasing ATPase levels. N-SNPs caused extensive ultrastructural alterations in cell and nuclear structures, as well as in various organelles. Furthermore, N-SNPs triggered apoptosis via the activation of caspase 3 and p53, and suppressed the mTOR signaling pathway via downregulating apoptosis-evading proteins in MCF-7, HCT-116, and HepG2 cells. Ultrastructural analysis, together with biochemical and molecular analyses, revealed that N-SNPs enhanced apoptosis via the induction of oxidative stress and/or through direct interactions with cellular structures in all tested cells. The cytotoxicity of Nostoc-mediated SNPs represents a new strategy for cancer treatment via targeting various cell death pathways. However, the potential of N-SNPs to be usable and biocompatible anticancer drug will depend on their toxicity against normal cells.